Why Fewer Clinical Trials in Africa is Bad for Innovation
"The African continent offers many of the best conditions for conducting clinical trials. It has a diverse population of potential patients, and many have not been previously exposed to any kind of pharmaceutical drugs ... So it makes sense to run clinical trials for drugs that would treat diseases endemic to the developing world in the areas most affected by them," writes Swapan Kumar Patra for The Conversation.
The Conversation Africa, 4 June 2018
Clinical trials are the foundation of any new medicine. They allow scientists to test the efficacy and safety of a drug or therapy. Read more »